Characterization of maltocin P28, a novel phage tail-like bacteriocin from Stenotrophomonas maltophilia
- PMID:23835182
- PMCID: PMC3754179
- DOI: 10.1128/AEM.01648-13
Characterization of maltocin P28, a novel phage tail-like bacteriocin from Stenotrophomonas maltophilia
Abstract
Stenotrophomonas maltophilia is an important global opportunistic pathogen for which limited therapeutics are available because of the emergence of multidrug-resistant strains. A novel bacteriocin, maltocin P28, which is produced by S. maltophilia strain P28, may be the first identified phage tail-like bacteriocin from S. maltophilia. Maltocin P28 resembles a contractile but nonflexible phage tail structure based on electron microscopy, and it is sensitive to trypsin, proteinase K, and heat. SDS-PAGE analysis of maltocin P28 revealed two major protein bands of approximately 43 and 20 kDa. The N-terminal amino acid residues of these two major subunits were sequenced, and the maltocin P28 gene cluster was located on the S. maltophilia P28 chromosome. Our sequence analysis results indicate that this maltocin gene cluster consists of 23 open reading frames (ORFs), and that its gene organization is similar to that of the P2 phage genome and R2 pyocin gene cluster. ORF17 and ORF18 encode the two major structural proteins, which correspond to gpFI (tail sheath) and gpFII (tail tube) of P2 phage, respectively. We found that maltocin P28 had bactericidal activity against 38 of 81 tested S. maltophilia strains. Therefore, maltocin P28 is a promising therapeutic substitute for antibiotics for S. maltophilia infections.
Figures






Similar articles
- Characterization of maltocin S16, a phage tail-like bacteriocin with antibacterial activity against Stenotrophomonas maltophilia and Escherichia coli.Chen J, Zhu Y, Yin M, Xu Y, Liang X, Huang YP.Chen J, et al.J Appl Microbiol. 2019 Jul;127(1):78-87. doi: 10.1111/jam.14294. Epub 2019 May 15.J Appl Microbiol. 2019.PMID:31021024
- Regulation of maltocin synthesis in Stenotrophomonas maltophilia by positive and negative regulators.Sun W, Liang X, Zhu C, Xu Y, Ding Y, Huang YP.Sun W, et al.Res Microbiol. 2022 Jul-Sep;173(6-7):103956. doi: 10.1016/j.resmic.2022.103956. Epub 2022 May 13.Res Microbiol. 2022.PMID:35569725
- Antibacterial Activity of Stenotrophomonas maltophilia Endolysin P28 against both Gram-positive and Gram-negative Bacteria.Dong H, Zhu C, Chen J, Ye X, Huang YP.Dong H, et al.Front Microbiol. 2015 Nov 24;6:1299. doi: 10.3389/fmicb.2015.01299. eCollection 2015.Front Microbiol. 2015.PMID:26635765Free PMC article.
- Detection of a phage genome carrying a zonula occludens like toxin gene (zot) in clinical isolates of Stenotrophomonas maltophilia.Hagemann M, Hasse D, Berg G.Hagemann M, et al.Arch Microbiol. 2006 Jun;185(6):449-58. doi: 10.1007/s00203-006-0115-7. Epub 2006 May 4.Arch Microbiol. 2006.PMID:16775751
- Isolation and characterization of a novel filamentous phage from Stenotrophomonas maltophilia.Liu J, Liu Q, Shen P, Huang YP.Liu J, et al.Arch Virol. 2012 Sep;157(9):1643-50. doi: 10.1007/s00705-012-1305-z. Epub 2012 May 22.Arch Virol. 2012.PMID:22614810
Cited by
- Advances in the Microbiology of Stenotrophomonas maltophilia.Brooke JS.Brooke JS.Clin Microbiol Rev. 2021 Jun 16;34(3):e0003019. doi: 10.1128/CMR.00030-19. Epub 2021 May 26.Clin Microbiol Rev. 2021.PMID:34043457Free PMC article.
- The Potential of Phage Therapy against the Emerging Opportunistic PathogenStenotrophomonas maltophilia.McCutcheon JG, Dennis JJ.McCutcheon JG, et al.Viruses. 2021 Jun 3;13(6):1057. doi: 10.3390/v13061057.Viruses. 2021.PMID:34204897Free PMC article.Review.
- Characterization and Genomic Analysis of ɸSHP3, a New Transposable Bacteriophage Infecting Stenotrophomonas maltophilia.Wu H, Zhang Y, Jiang Y, Wu H, Sun W, Huang YP.Wu H, et al.J Virol. 2021 Apr 12;95(9):e00019-21. doi: 10.1128/JVI.00019-21. Print 2021 Apr 12.J Virol. 2021.PMID:33536173Free PMC article.
- Outer membrane vesicles from a mosquito commensal mediate targeted killing of Plasmodium parasites via the phosphatidylcholine scavenging pathway.Gao H, Jiang Y, Wang L, Wang G, Hu W, Dong L, Wang S.Gao H, et al.Nat Commun. 2023 Aug 24;14(1):5157. doi: 10.1038/s41467-023-40887-6.Nat Commun. 2023.PMID:37620328Free PMC article.
- Rhizoviticin is an alphaproteobacterial tailocin that mediates biocontrol of grapevine crown gall disease.Ishii T, Tsuchida N, Hemelda NM, Saito K, Bao J, Watanabe M, Toyoda A, Matsubara T, Sato M, Toyooka K, Ishihama N, Shirasu K, Matsui H, Toyoda K, Ichinose Y, Hayashi T, Kawaguchi A, Noutoshi Y.Ishii T, et al.ISME J. 2024 Jan 8;18(1):wrad003. doi: 10.1093/ismejo/wrad003.ISME J. 2024.PMID:38365227Free PMC article.
References
- Ryan RP, Monchy S, Cardinale M, Taghavi S, Crossman L, Avison MB, Berg G, Lelie D, Dow JM. 2009. The versatility and adaptation of bacteria from the genus Stenotrophomonas. Nat. Rev. Microbiol. 7:514–525 - PubMed
- Looney WJ, Narita M, Mühlemann K. 2009. Stenotrophomonas maltophilia: an emerging opportunist human pathogen. Lancet Infect. Dis. 9:312–323 - PubMed
- Bin Abdulhak AA, Zimmerman V, Al Beirouti BT, Baddour LM, Tleyjeh IM. 2009. Stenotrophomonas maltophilia infections of intact skin: a systematic review of the literature. Diagn. Microbiol. Infect. Dis. 63:330–333 - PubMed
- Paez JI, Tengan FM, Barone AA, Levin AS, Costa SF. 2008. Factors associated with mortality in patients with bloodstream infection and pneumonia due to Stenotrophomonas maltophilia. Eur. J. Clin. Microbiol. Infect. Dis. 27:901–906 - PubMed
Publication types
MeSH terms
Substances
Associated data
- Actions
- Actions
Related information
LinkOut - more resources
Full Text Sources
Other Literature Sources